The FDA and Escozine stuff is all good - BUT right now, this instant they're on the cusp of the "BIG LAUNCH" of their rebranded consumer line as now Aelia brand products.
IN THE NEAR-TERM I believe the AELIA BRAND SALES are the key item here !
Without a SHRED of professional marketing, branding or any "advertising" I can find in the past - they have maintained approx $1.5 million in revenues at the old sleepy QNTA.
IF they get this MedoLife Rx new corp name and NEW TICKER change done- and can CUT TONY HAWK LOOSE on this puppy and newly packed products which look light years better than the old stuff - they can make 5X to 10X that sales number in RAPID FORM IMO !
AND THAT = they can become "self financed" and will have no need for anymore dilution, etc.
THEY NEED TO GET THE AELIA BRAND OFF THE GROUND ASAP - they said, "A few weeks" from the Tony Hawk endorsement PR which is RIGHT ABOUT NOW on the calendar = we should hit pay dirt here pretty soon IMO:
June 17 and it says, "We should be re-branded and ready to launch in a few weeks or close to that time frame from this PR" blah blah.
July 9th today = JUST ABOUT TIME TO KICK-OFF THE AELIA STORE and BRAND and get those revenues into high gear - like up to $5 MILLION annual very rapidly IMO !
THAT is the key piece here ASAP IMO - AND a new ticker/corp name change = that would launch this back up to or above prior near-term highs IMO!
News 
Market Data 
Discover 
